Cite
HARVARD Citation
Zhou, H. et al. (2020). Cost-effectiveness of omalizumab for the treatment of inadequately controlled severe allergic asthma in Chinese children. Journal of asthma. pp. 87-94. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhou, H. et al. (2020). Cost-effectiveness of omalizumab for the treatment of inadequately controlled severe allergic asthma in Chinese children. Journal of asthma. pp. 87-94. [Online].